Alerta De Seguridad para POWERHEART AUTOMATIC EXTERNAL DEFIBRILLATOR. Models existing in Brazil that may be affected: 9300A, 9300C, 9300E and 9300P, produced between August 2003 and August 2009. ANVISA records: 10265410052 (Tecnimed Comercial Ltda) and 10312210014 (Medcorp Hospitalar Ltda). Affected serial numbers: check at www.cardiacscience.com/AED175.

Según Agência Nacional de Vigilância Sanitária (ANVISA), este evento ( alerta de seguridad ) involucró a un dispositivo médico en Brazil que fue producido por Tecnimed/Paramedics Eletromedicina Comercial Ltda e Medcorp Hospitalar Ltda; Cardiac Science Corporation.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • ID del evento
    1002
  • Fecha
    2010-01-15
  • País del evento
  • Fuente del evento
    ANVISA
  • URL de la fuente del evento
  • Notas / Alertas
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notas adicionales en la data
    Cardiac Science Corporation has initiated a voluntary field action for POWERHEART automatic defibrillators due to a problem that affects the electronic components of some of these devices. According to information received by the Anvisa Technovigilance Unit (UTVIG / ANVISA), the problem may be related to the operation of resistors that equip the defibrillators. In order to correct the problem, Cardiac Science Corporation has already started the development of a software update for the affected equipment, which should be installed in the equipment that is in the field as of May 2010. The UTVIG / ANVISA has already initiated contact with the holders of product registration in Brazil and is following up on this case.
  • Causa
    Equipment may not release therapeutic electrical discharge, compromising the patient's resuscitation procedure.
  • Acción
    The manufacturer (Cardiac Science Corporation) has initiated product corrective action (upgrade software), which is expected to be available through May 2010. It is recommended that users replace defibrillators at use by backup equipment, if possible, until the update is made by the registry holder. If replacement of the affected equipment is not possible, it should be used normally and the maintenance provided in the manuals should be performed routinely. It is also essential that users periodically check the operating status indicator of each device on the front of the device.